Attached

Novelix Pharmaceuticals limited (Formerly TRIMURTHI LIMITED) CIN: L67120TG1994PLC018956 (NOVELIX | 536565 | INE314I01036) Date: 30th September, 2026 The Deputy Manager (Department of Corporate Affairs), BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai-400001. Sub.: Intimation of Closure of Trading Window. Ref.: Scrip Id: NOVELIX Scrip Code: 536565 Respected Sir/Madam, In terms of the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 (“PIT Regulations”) as amended and in compliance Code of Conduct for Prevention of Insider Trading, we wish to inform you that the Trading Window for dealing in the securities of the Company will remain closed for Designated Persons of the Company and their relatives with effect from Thursday, October 1, 2026, till 48 hours after the declaration of Unaudited Financial Results for the quarter and half year ended on September 30, 2026. The date of consideration of the aforesaid Financial Results shall be intimated in due course. Accordingly, all the Designated persons and their relatives and other Insiders under the PIT Regulations are directed not to trade in the securities of the Company during the aforesaid trading window closure period. Thanking you, Yours faithfully, For Novelix Pharmaceuticals Limited Venkateshwarlu Pulluru (Whole-time director) DIN: 02076871 Novelix Pharmaceuticals limited (Formerly Known as TRIMURTHI LIMITED) H No: 3-6-237/610, Flat No: 610, 6Th Floor, Lingapur LA Builders, Also Known as Amrutha Estates, Himayat Nagar, Hyderabad, Telangana- 500029 Ph No: +91 8977631044 Email: novelixpharmaceuticals@gmail.com www.novelixpharma.com